✦ LIBER ✦

Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial

✍ Scribed by Lorenzen, S; Duyster, J; Lersch, C; von Delius, S; Hennig, M; Bredenkamp, R; Peschel, C; Lordick, F

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel/Gemcitabine Administered Every

✍ Amadeu Pelegrí; Lourdes Calvo; Antonio Antón; José I. Mayordomo; Jesús Florián; 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 107 KB

Gemcitabine plus docetaxel administered

✍ Amadeu Pelegrı́; Lourdes Calvo; José I Mayordomo; Jesús Florián; Santiago Vázque 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Final Results of a Phase II Clinical Tri

✍ John R. Mackey; Katia S. Tonkin; Sheryl L. Koski; Andrew G. Scarfe; Michael G.B. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 329 KB

Phase II trial of capecitabine plus cisp

✍ Daniel T. T. Chua; Harry Ho-Yin Yiu; Kasan Seetalarom; Alice Wan-Ying Ng; Johan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

5054 Safety and efficacy of the combinat

✍ V. Michalaki; S. Gennatas; C. Gennatas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Final results of a phase II study of bev

✍ S. Hurvitz; H.J. Allen; R.L. Moroose; D. Chan; C. Hagenstad; S.H. Applebaum; G. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB